SCHEMBL16678890

SCHEMBL16678890

ClN1CCC(OCCN2CCOCC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.50
▸ LIPG Q9Y5X9 1/20 0.39
▸ MCHR1 Q99705 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ EPHX2 P34913 1/20 0.38
▸ TSHR P16473 2/20 0.37
▸ KEAP1 Q14145 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ SIGMAR1 Q99720 2/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRM1 P11229 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ SCN1A P35498 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ SCN2A Q99250 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13086520 0.84 NPC1 (0.52) NPC1LIPGMCHR1ALDH1A1KDM4E
SCHEMBL18855748 0.84 NPC1 (0.71) NPC1LIPGMCHR1ALDH1A1KDM4E
SCHEMBL9703528 0.82 NPC1 (0.75) NPC1LIPGMCHR1ALDH1A1KDM4E
SCHEMBL8263002 0.79 NPC1 (0.50) NPC1LIPGMCHR1ALDH1A1EPHX2
SCHEMBL79064 0.79 NPC1 (0.50) NPC1LIPGMCHR1ALDH1A1KDM4E
SCHEMBL13993536 0.79 NPC1 (0.50) NPC1LIPGMCHR1ALDH1A1EPHX2
SCHEMBL13741291 0.79 HRH3 (0.51) NPC1LIPGMCHR1EPHX2HRH3
Hydrochloric Acid SCHEMBL15352413 0.78 NPC1 (0.49) NPC1LIPGMCHR1ALDH1A1KDM4E
SCHEMBL13866421 0.76 NPC1 (0.46) NPC1LIPGMCHR1ALDH1A1EPHX2
SCHEMBL12820372 0.76 NPC1 (0.46) NPC1LIPGMCHR1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150119373-A1 NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS HETERO LABS LIMITED (IN) 2015-04-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119373-A1 NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS BET1, PGGT1B, RABGGTB NPC1 802/4885LIPG 1026/4885MCHR1 4703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback